Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart

被引:137
作者
Flarsheim, CE [1 ]
Grupp, IL [1 ]
Matlib, MA [1 ]
机构
[1] UNIV CINCINNATI, COLL MED, DEPT PHYSIOL & BIOPHYS, CINCINNATI, OH 45267 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1996年 / 271卷 / 01期
关键词
diabetes; mitochondria; calcium transport; oxidative phosphorylation; cardiomyopathy;
D O I
10.1152/ajpheart.1996.271.1.H192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to determine whether a defect in mitochondrial respiratory function accompanies the development of diabetic cardiomyopathy. The hypothesis tested in this study is that a decrease in Ca2+ uptake into mitochondria may prevent the stimulation of Ca2+-sensitive matrix dehydrogenase and the rate of ATP synthesis. Streptozotocin (55 mg/kg)-induced diabetic rats were used as a model of insulin-dependent diabetes mellitus. Hearts from 4-wk diabetic rats had basal heart rates and rates of contraction and relaxation similar to control. Isoproterenol caused a similar increase in the rate of contraction in diabetic and control hearts, whereas the peak rate of relaxation was reduced in diabetic hearts. Mitochondrial Ca2+ uptake was reduced in mitochondria from diabetic hearts after 2 wk of diabetes. Na+-induced Ca2+ release was unchanged. State 3 respiration rate was depressed in mitochondria from diabetic rats only when the respiration was supported by the substrate of a Ca2+-regulated matrix enzyme. The pyruvate dehydrogenase activity was reduced in diabetic mitochondria compared with that of control. It was concluded that mitochondria from diabetic hearts had a decreased capacity to upregulate ATP synthesis via stimulation of Ca2+-sensitive matrix dehydrogenases. The impairment in the augmentation of ATP synthesis rate accompanies a decreased rate of relaxation during increased work load.
引用
收藏
页码:H192 / H202
页数:11
相关论文
共 36 条
[1]   REDUCED HIGH-ENERGY PHOSPHATE LEVELS IN RAT HEARTS .1. EFFECTS OF ALLOXAN DIABETES [J].
ALLISON, TB ;
BRUTTIG, SP ;
CRASS, MF ;
ELIOT, RS ;
SHIPP, JC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1976, 230 (06) :1744-1750
[2]  
BABA A, 1991, J APPL CARDIOL, V6, P325
[3]  
COX DA, 1993, J BIOL CHEM, V268, P938
[4]  
DENTON RM, 1988, J CARDIOVASC PHARM, V12, pS69
[5]   LONGEVITY OF DIABETIC PATIENTS IN RECENT YEARS [J].
ENTMACHER, PS ;
MARKS, HH ;
ROOT, HF .
DIABETES, 1964, 13 (04) :373-&
[6]  
Estabrook R.W., 1967, METHODS ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
[7]   REVERSIBILITY OF DIABETIC CARDIOMYOPATHY WITH INSULIN IN RATS [J].
FEIN, FS ;
STROBECK, JE ;
MALHOTRA, A ;
SCHEUER, J ;
SONNENBLICK, EH .
CIRCULATION RESEARCH, 1981, 49 (06) :1251-1261
[8]   ALTERED MYOCARDIAL MECHANICS IN DIABETIC RATS [J].
FEIN, FS ;
KORNSTEIN, LB ;
STROBECK, JE ;
CAPASSO, JM ;
SONNENBLICK, EH .
CIRCULATION RESEARCH, 1980, 47 (06) :922-933
[9]   DIABETIC CARDIOMYOPATHY [J].
FEIN, FS ;
SONNENBLICK, EH .
CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (01) :65-73
[10]  
GRUPP IL, 1984, METHOD PHARMACOL, V5, P111